Literature DB >> 15477343

Esophageal cancer: preoperative or definitive chemoradiation.

S Urba1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15477343     DOI： 10.1093/annonc/mdh910

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.

Authors:  Matthias Felix Haefner; Kristin Lang; Vivek Verma; Stefan Alexander Koerber; Lorenz Uhlmann; Juergen Debus; Florian Sterzing
Journal:  Strahlenther Onkol       Date:  2017-09-15       Impact factor: 3.621

2.  Phase II study of concurrent chemoradiotherapy with a modified target volumes delineation method for inoperable oesophagealcancer patients.

Authors:  Wenyi Zhang; Huifang Li; Xingxing Chen; Meng Su; Ruifang Lin; Changlin Zou
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

3.  Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study.

Authors:  Ioannis Rouvelas; Wenyi Zeng; Mats Lindblad; Pernilla Viklund; Weimin Ye; Jesper Lagergren
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

4.  Evaluation of the safety and effectiveness of neoadjuvant combined chemoimmunotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective single-arm cohort study.

Authors:  Pinghui Xia; Pan Li; Simeng Wu; Yiqing Wang; Peng Ye; Chong Zhang; Jian Hu; Biniam Kidane; Savvas Lampridis; Jeffrey B Velotta; Connor J Wakefield; Linhai Zhu; Luming Wang
Journal:  Ann Transl Med       Date:  2022-09

5.  Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.

Authors:  Michelle A T Hildebrandt; Hushan Yang; Mien-Chie Hung; Julie G Izzo; Maosheng Huang; Jie Lin; Jaffer A Ajani; Xifeng Wu
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544

6.  A single-nucleotide-polymorphism in the 5'-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma.

Authors:  Takahiro Mori; Kazuko Ueno; Katsushi Tokunaga; Yosuke Kawai; Koichi Matsuda; Nao Nishida; Keigo Komine; Sakae Saito; Masao Nagasaki
Journal:  Ther Adv Med Oncol       Date:  2022-02-24       Impact factor: 8.168

7.  A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagus.

Authors:  Bahram Mofid; Abolfazl Razzaghdoust; Amir Shahram Yousefi Kashi; Hamid Reza Mirzaei
Journal:  Electron Physician       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.